169 related articles for article (PubMed ID: 18613223)
1. Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients.
Wassenaar T; Black J; Kahl B; Schwartz B; Longo W; Mosher D; Williams E
Hematol Oncol; 2008 Dec; 26(4):241-6. PubMed ID: 18613223
[TBL] [Abstract][Full Text] [Related]
2. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
Schwartz BS; Williams EC; Conlan MG; Mosher DF
Ann Intern Med; 1986 Dec; 105(6):873-7. PubMed ID: 3465267
[TBL] [Abstract][Full Text] [Related]
3. Plasma proteinase inhibitor activity and hemostasis tests in children with nephrotic syndrome. Effect of prednisone alone and prednisone plus epsilon-aminocaproic acid treatment regimens: a preliminary report.
Prandota J; Pankow-Prandota L; Kotecki L; Noga L
Am J Ther; 2001; 8(2):97-107. PubMed ID: 11304663
[TBL] [Abstract][Full Text] [Related]
4. Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
Williams EC
Arch Intern Med; 1989 Aug; 149(8):1769-72. PubMed ID: 2475079
[TBL] [Abstract][Full Text] [Related]
5. [Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)].
Ryo R; Sugano W; Yoshida A; Adachi M; Yasunaga M; Yoneda N; Saigo K; Kondo S; Yamaguchi N; Nobusawa A
Gan No Rinsho; 1989 Oct; 35(12):1479-82. PubMed ID: 2810783
[TBL] [Abstract][Full Text] [Related]
6. Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass.
Ray MJ; Hales M; Marsh N
Blood Coagul Fibrinolysis; 2001 Mar; 12(2):129-35. PubMed ID: 11302475
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
Meyer K; Williams EC
Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
[TBL] [Abstract][Full Text] [Related]
8. Epsilon-aminocaproic acid and renal complications: case report and review of the literature.
Manjunath G; Fozailoff A; Mitcheson D; Sarnak MJ
Clin Nephrol; 2002 Jul; 58(1):63-7. PubMed ID: 12141409
[TBL] [Abstract][Full Text] [Related]
9. Termination of bleeding by a specific, anticatalytic antibody against plasmin.
Zhao T; Houng A; Reed GL
J Thromb Haemost; 2019 Sep; 17(9):1461-1469. PubMed ID: 31136076
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant use of epsilon-aminocaproic acid (Amicar) in the endovascular treatment of cranial arteriovenous fistulae.
Kallmes DF; Marx WF; Jensen ME; Cloft HJ; Do HM; Lanzino G; West K; Dion JE
Neuroradiology; 2000 Apr; 42(4):302-8. PubMed ID: 10872177
[TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
Estcourt LJ; Desborough M; Brunskill SJ; Doree C; Hopewell S; Murphy MF; Stanworth SJ
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009733. PubMed ID: 26978005
[TBL] [Abstract][Full Text] [Related]
12. Epsilon-aminocaproic acid (EACA).
Griffin JD; Ellman L
Semin Thromb Hemost; 1978; 5(1):27-40. PubMed ID: 568312
[TBL] [Abstract][Full Text] [Related]
13. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
[TBL] [Abstract][Full Text] [Related]
14. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
[TBL] [Abstract][Full Text] [Related]
15. Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery.
Berenholtz SM; Pham JC; Garrett-Mayer E; Atchison CW; Kostuik JP; Cohen DB; Nundy S; Dorman T; Ness PM; Klag MJ; Pronovost PJ; Kebaish KM
Spine (Phila Pa 1976); 2009 Sep; 34(19):2096-103. PubMed ID: 19730217
[TBL] [Abstract][Full Text] [Related]
16. Epsilon-Aminocaproic Acid Has No Association With Thromboembolic Complications, Renal Failure, or Mortality After Liver Transplantation.
Nicolau-Raducu R; Ku TC; Ganier DR; Evans BM; Koveleskie J; Daly WJ; Fish B; Cohen AJ; Reichman TW; Bohorquez HE; Bruce DS; Carmody IC; Loss GE; Gitman M; Marshall T; Nossaman BD
J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):917-23. PubMed ID: 27020101
[TBL] [Abstract][Full Text] [Related]
17. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
[TBL] [Abstract][Full Text] [Related]
18. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
[TBL] [Abstract][Full Text] [Related]
19. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage.
Starke RM; Kim GH; Fernandez A; Komotar RJ; Hickman ZL; Otten ML; Ducruet AF; Kellner CP; Hahn DK; Chwajol M; Mayer SA; Connolly ES
Stroke; 2008 Sep; 39(9):2617-21. PubMed ID: 18658042
[TBL] [Abstract][Full Text] [Related]
20. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia.
Avvisati G; ten Cate JW; Sturk A; Lamping R; Petti MG; Mandelli F
Br J Haematol; 1988 Sep; 70(1):43-8. PubMed ID: 2460126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
